
  
    
      
        
        Recently_RB 
        PLoS_NNP Medicine_NNP published_VBD our_PRP$ paper_NN entitled_VBD “ Designing_NNP Equitable_NNP
        Antiretroviral_NNP Allocation_NNP Strategies_NNS in_IN Resource-_NNP Constrained_NNP Countries_NNPS” [_NN 1_CD ]_NN ._. We_PRP were_VBD
        disappointed_VBN to_TO find_VB that_IN the_DT editorial_NN perspective_NN written_VBN by_IN the_DT World_NNP Health_NNP
        Organization_NNP (_( WHO_WP )_) ethicists_NNS regarding_VBG our_PRP$ paper_NN [_NN 2_CD ]_NN was_VBD based_VBN upon_IN a_DT substantial_JJ
        misunderstanding_VBG of_IN our_PRP$ novel_NN quantitative_JJ analyses_NNS and_CC our_PRP$ important_JJ results_NNS ._. Hence_RB ,_, they_PRP
        misunderstood_VBN the_DT significance_NN of_IN the_DT health-policy_JJ implications_NNS of_IN our_PRP$ results_NNS ._. Thus_RB ,_, we_PRP
        wish_VBP to_TO correct_VB the_DT record_NN ._.
        Firstly_NNP ,_, Capron_NNP and_CC Reis_NNP [_NN 2_CD ]_NN misunderstood_VBN our_PRP$ quantitative_JJ analyses_NNS ._. They_PRP stated_VBD that_IN
        “ Wilson_NNP and_CC Blower_NNP developed_VBD a_DT mathematical_JJ model_NN that_WDT could_MD inform_VB policy-makers_NNS '_POS
        decisions_NNS regarding_VBG the_DT optimal_NN distribution_NN of_IN treatment_NN sites_NNS to_TO ensure_VB equal_JJ access_NN by_IN
        all_DT individuals_NNS infected_VBN with_IN HIV_NNP ._.” However_RB ,_, our_PRP$ model_NN does_VBZ not_RB determine_VB the_DT optimal_NN
        distribution_NN of_IN treatment_NN sites_NNS ._. As_IN we_PRP clearly_RB state_VBP in_IN our_PRP$ paper_NN [_NN 1_CD ]_NN (_( and_CC is_VBZ also_RB stated_VBN
        in_IN the_DT synopsis_NNS [_NN 3_CD ]_NN )_) ,_, we_PRP developed_VBD a_DT model_NN that_IN policy_NN makers_NNS can_MD use_VB to_TO make_VB decisions_NNS
        regarding_VBG how_WRB to_TO achieve_VB the_DT optimal_NN allocation_NN of_IN scarce_JJ antiretrovirals_NNS among_IN the_DT
        available_JJ health-care_NN facilities_NNS (_( HCFs_NNP )_) if_IN the_DT objective_NN is_VBZ to_TO ensure_VB treatment_NN equity_NN ._. We_PRP
        also_RB calculated_VBD how_WRB the_DT optimal_NN allocation_NN of_IN antiretrovirals_NNS would_MD vary_VB if_IN the_DT number_NN of_IN
        HCFs_NNP utilized_JJ increased_VBD and_CC /_NN or_CC the_DT size_NN of_IN the_DT catchment_NN area_NN that_IN each_DT HCF_NNP services_NNS
        increased_VBD [_NN 1_CD ]_NN ._. Thus_RB ,_, we_PRP took_VBD the_DT treatment_NN sites_NNS (_( i_NNP ._. e_SYM ._. ,_, HCFs_NNP )_) as_IN given_VBN ,_, and_CC we_PRP used_VBD their_PRP$
        specific_JJ spatial_NN location_NN in_IN South_NNP Africa_NNP as_IN inputs_NNS to_TO our_PRP$ model_NN in_IN order_NN to_TO determine_VB
        optimal_NN antiretroviral_NN allocation_NN strategies_NNS under_IN a_DT variety_NN of_IN conditions_NNS ._.
        Secondly_RB ,_, Capron_NNP and_CC Reis_NNP [_NN 2_CD ]_NN misunderstood_VBN our_PRP$ important_JJ results_NNS ._. They_PRP stated_VBD that_IN
        “ applying_VBG this_DT tool_NN to_TO the_DT South-_NNP African_JJ province_NN of_IN KwaZulu–Natal_NNP ,_, Wilson_NNP and_CC Blower_NNP were_VBD
        able_JJ to_TO confirm_VB mathematically_RB the_DT intuitive_JJ assumption_NN that_IN using_VBG a_DT maximum_NN number_NN of_IN
        centers_NNS ,_, at_IN the_DT least_JJS possible_JJ distance_NN from_IN most_RBS affected_VBN populations_NNS ,_, would_MD lead_VB to_TO the_DT
        greatest_JJS fairness_NN in_IN the_DT geographical_JJ distribution_NN of_IN ART_NNP [_NN antiretroviral_NN therapy_NN ]_NN ._.” We_PRP
        agree_VBP that_IN if_IN these_DT had_VBD been_VBN our_PRP$ results_NNS ,_, they_PRP would_MD have_VB been_VBN trivial_JJ and_CC obvious_JJ ._.
        However_RB ,_, Capron_NNP and_CC Reis_NNP [_NN 2_CD ]_NN did_VBD not_RB discuss_VB our_PRP$ actual_JJ results_NNS :_: we_PRP determined_VBD how_WRB to_TO
        decide_VB how_WRB many_JJ drugs_NNS to_TO allocate_VB to_TO each_DT of_IN the_DT available_JJ HCFs_NNP in_IN order_NN to_TO achieve_VB an_DT
        optimal_NN allocation_NN if_IN the_DT objective_NN is_VBZ to_TO ensure_VB treatment_NN equity_NN ._. This_DT is_VBZ a_DT very_RB complex_JJ
        problem_NN and_CC the_DT antiretroviral_NN allocation_NN strategies_NNS that_IN we_PRP calculated_VBD (_( by_IN using_VBG our_PRP$
        model_NN )_) to_TO be_VB optimal_NN are_VBP very_RB complex_JJ (_( see_VB Figure_NN 3_CD in_IN our_PRP$ paper_NN ,_, which_WDT graphically_RB shows_VBZ
        the_DT proportion_NN of_IN drugs_NNS that_WDT should_MD be_VB allocated_VBN to_TO each_DT of_IN the_DT available_JJ HCFs_NNP )_) ._.
        Furthermore_RB ,_, we_PRP also_RB determined_VBD what_WP catchment_NN area_NN each_DT HCF_NNP should_MD service_VB ;_: specifically_RB ,_,
        we_PRP calculated_VBD that_IN each_DT HCF_NNP should_MD serve_VB (_( if_IN the_DT objective_NN is_VBZ to_TO achieve_VB treatment_NN equity_NN )_)
        a_DT catchment_NN area_NN of_IN 40_CD –_NN 60_CD km_NN ._. Thus_RB ,_, our_PRP$ results_NNS demonstrate_VBP (_( to_TO our_PRP$ knowledge_NN for_IN the_DT first_JJ
        time_NN )_) that_WDT patients_NNS infected_VBN with_IN HIV_NNP will_MD have_VB to_TO travel_VB extremely_RB large_JJ distances_NNS (_( i_NNP ._. e_SYM ._. ,_,
        40_CD -_: –_NN 60_CD km_NN )_) in_IN order_NN to_TO receive_VB antiretrovirals_NNS ,_, if_IN the_DT objective_NN is_VBZ to_TO achieve_VB treatment_NN
        equity_NN in_IN South_NNP Africa_NNP ._. We_PRP stress_VBP that_IN currently_RB it_PRP is_VBZ unknown_JJ what_WP the_DT actual_JJ size_NN of_IN the_DT
        catchment_NN area_NN is_VBZ around_IN HCFs_NNP in_IN South_NNP Africa_NNP ._. Catchment_NNP areas_NNS may_MD in_IN fact_NN be_VB very_RB small_JJ ._.
        Thus_RB ,_, we_PRP suggested_VBD [_NN 1_CD ]_NN that_IN a_DT primary_JJ goal_NN should_MD be_VB to_TO obtain_VB empirical_JJ data_NNS of_IN the_DT
        distances_NNS that_IN patients_NNS in_IN South_NNP Africa_NNP are_VBP willing_JJ (_( or_CC able_JJ )_) to_TO travel_VB in_IN order_NN to_TO receive_VB
        antiretrovirals_NNS ._. We_PRP have_VBP been_VBN the_DT first_JJ to_TO provide_VB a_DT quantitative_JJ assessment_NN of_IN the_DT
        necessary_JJ size_NN of_IN the_DT catchment_NN area_NN ,_, and_CC our_PRP$ results_NNS have_VBP identified_VBN that_IN there_EX is_VBZ an_DT
        urgent_JJ need_VBP to_TO collect_VB these_DT critical_JJ data_NN for_IN quantifying_VBG the_DT size_NN of_IN the_DT catchment_NN areas_NNS
        around_IN HCFs_NNP ._. We_PRP have_VBP determined_VBN that_IN the_DT size_NN of_IN the_DT catchment_NN area_NN will_MD be_VB a_DT critical_JJ
        component_NN in_IN the_DT ability_NN to_TO achieve_VB treatment_NN equity_NN in_IN South_NNP Africa_NNP ._. We_PRP also_RB compared_VBD the_DT
        optimal_NN antiretroviral_NN allocation_NN strategies_NNS that_IN we_PRP calculated_VBD with_IN the_DT current_JJ plan_NN of_IN
        the_DT South_JJ African_JJ government_NN for_IN allocating_VBG antiretrovirals_NNS [_NN 4_CD ]_NN ,_, and_CC we_PRP determined_VBD that_IN the_DT
        current_JJ antiretroviral_NN allocation_NN strategies_NNS in_IN South_NNP Africa_NNP will_MD not_RB achieve_VB treatment_NN
        equity_NN ._. Taken_VBN together_RB ,_, our_PRP$ quantitative_JJ results_NNS are_VBP novel_NN and_CC controversial_JJ ,_, providing_VBG
        important_JJ quantitative_JJ insights_NNS into_IN a_DT complex_JJ public-health_NN problem_NN ._.
        We_PRP applaud_VBP the_DT ambitious_JJ “ 3_CD by_IN 5_CD” WHO_WP target_NN for_IN the_DT antiretroviral_NN rollout_NN ._. However_RB ,_,
        the_DT WHO_WP has_VBZ not_RB yet_RB devised_VBD a_DT quantitative_JJ policy_NN for_IN determining_VBG how_WRB to_TO allocate_VB
        antiretrovirals_NNS in_IN situations_NNS where_WRB the_DT demand_NN for_IN drugs_NNS greatly_RB exceeds_VBZ the_DT supply_NN [_NN 5_CD ]_NN ._.
        Health-policy_NNP officials_NNS in_IN each_DT country_NN will_MD have_VB to_TO make_VB these_DT important_JJ and_CC difficult_JJ
        decisions_NNS ,_, and_CC they_PRP will_MD all_DT make_VBP different_JJ decisions_NNS based_VBN upon_IN what_WP objectives_NNS they_PRP wish_VBP
        to_TO optimize_NN and_CC prioritize_NN ._. There_EX are_VBP a_DT multitude_NN of_IN factors_NNS to_TO consider_VB (_( these_DT factors_NNS are_VBP
        well_RB described_VBN in_IN the_DT recent_JJ 
        Institute_NNP of_IN Medicine_NNP report_NN [_NN 6_CD ]_NN )_) ._. We_PRP stress_VBP that_IN the_DT alternative_NN to_TO a_DT
        quantitative_JJ rational_JJ approach_NN for_IN allocating_VBG scarce_JJ resources_NNS is_VBZ an_DT ad_NN hoc_FW approach_NN ,_, which_WDT
        is_VBZ how_WRB the_DT scarce_JJ supply_NN of_IN antiretrovirals_NNS is_VBZ currently_RB being_VBG distributed_VBN in_IN many_JJ
        resource-constrained_JJ countries_NNS ._. Our_PRP$ operations_NNS research_NN modeling_NN approach_NN is_VBZ based_VBN upon_IN
        spatial_NN heterogeneity_NN in_IN the_DT distribution_NN of_IN HCFs_NNP in_IN South_NNP Africa_NNP and_CC the_DT spatial_NN
        heterogeneity_NN of_IN the_DT HIV-infected_NNP population_NN ._. The_DT most_RBS important_JJ “ real_JJ world_NN” result_NN is_VBZ
        that_IN we_PRP show_VBP that_IN what_WP the_DT South_JJ African_JJ government_NN is_VBZ currently_RB doing_VBG is_VBZ inequitable_JJ ._. We_PRP
        show_VBP them_PRP how_WRB to_TO achieve_VB equity_NN ,_, if_IN they_PRP wish_VBP to_TO do_VB so_RB ._. We_PRP hope_VBP that_IN our_PRP$ novel_NN approach_NN for_IN
        deciding_VBG how_WRB to_TO allocate_VB antiretrovirals_NNS will_MD be_VB of_IN use_NN to_TO the_DT WHO_WP and_CC also_RB to_TO the_DT relevant_JJ
        authorities_NNS in_IN the_DT many_JJ resource-constrained_JJ countries_NNS who_WP will_MD soon_RB have_VB to_TO make_VB very_RB
        difficult_JJ decisions_NNS as_IN to_TO who_WP lives_VBZ and_CC who_WP dies_VBZ ._. Our_PRP$ analysis_NN is_VBZ to_TO our_PRP$ knowledge_NN the_DT
        first_JJ analysis_NN to_TO show_VB how_WRB a_DT rational_JJ and_CC scientific_JJ solution_NN can_MD be_VB reached_VBN for_IN deciding_VBG
        how_WRB to_TO allocate_VB a_DT limited_JJ amount_NN of_IN antiretrovirals_NNS ,_, if_IN the_DT goal_NN is_VBZ to_TO achieve_VB treatment_NN
        equity_NN ._. Clearly_RB ,_, other_JJ goals_NNS must_MD be_VB taken_VBN into_IN consideration_NN (_( and_CC our_PRP$ model_NN can_MD be_VB
        modified_VBN to_TO include_VB these_DT other_JJ goals_NNS )_) ;_: however_RB ,_, we_PRP hope_VBP that_DT treatment_NN equity_NN will_MD be_VB a_DT
        very_RB high_JJ priority_NN during_IN the_DT antiretroviral_NN rollout_NN that_WDT is_VBZ just_RB beginning_VBG ._.
      
    
  
